triazoles has been researched along with vorinostat in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (90.91) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Q; Feng, C; Gu, G; Hou, J; Li, Z; Liu, P; Shen, J; Shi, Y; Wang, H; Wang, P; Xu, F; Yin, Z | 1 |
| Maxmen, A | 1 |
| Cabrera, SM; Colvin, SC; Maier, B; Mirmira, RG; Nadler, JL; Tersey, SA | 1 |
| McNeil, C | 1 |
| Bullen, CK; Durand, CM; Laird, GM; Siliciano, JD; Siliciano, RF | 1 |
| Annamalai, P; Gavara, G; Hiriyan, J; Natesan, S; Sambasivam, G; Shivarudraiah, P; Sukumaran, SK | 1 |
| Cheng, WJ; Churchill, MJ; Ellett, AM; Gorry, PR; Gray, LR; Jacobson, JC; Lewin, SR; Lu, HK; Moso, MA; On, H; Papaioannou, C; Purcell, DF; Raison, JA; Roberts, E; Wesselingh, SL | 1 |
| Alam, MZ; Chor, S; Ciotti, GE; Egolf, S; Eisinger-Mathason, TSK; Grazioli, A; Haldar, M; Lawlor, MA; Lee, AC; Marino, GE; Niedzwicki, D; Pak, K; Park, PMC; Perry, JA; Qi, J; Rivera-Reyes, A; Shah, J; Weber, K; Xu, M; Ye, S | 1 |
| Cam, DM; Choi, JE; Dung, DTM; Hai, PT; Han, SB; Hieu, DC; Huan, NV; Huong, LT; Kang, JS; Kim, J; Nam, NH | 1 |
| Babichev, Y; C Brady, D; Chor, S; E Ciotti, G; E Marino, G; Egolf, S; Eisinger-Mathason, TSK; Gladdy, R; Koumenis, C; Leli, NM; Liu, Y; Mancuso, A; Pak, K; Park, PMC; Posimo, JM; Qi, J; Rivera-Reyes, A; Sostre-Colón, J; Tameire, F; Weber, K; Ye, S | 1 |
| Li, H; Tu, B; Yin, G | 1 |
11 other study(ies) available for triazoles and vorinostat
| Article | Year |
|---|---|
Structure-based optimization of click-based histone deacetylase inhibitors.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; Click Chemistry; Crystallography, X-Ray; Drug Design; Drug Screening Assays, Antitumor; Histone Deacetylase 1; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Humans; Hydrophobic and Hydrophilic Interactions; Hydroxamic Acids; Models, Molecular; Neoplasms; Phenylalanine; Protein Binding; Protein Structure, Secondary; Structure-Activity Relationship; Triazoles; Vorinostat | 2011 |
Cancer research: Open ambition.
Topics: Adult; Animals; Azepines; Benzodiazepines; Cell Cycle Proteins; Child; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Leukemia; Male; Mice; Mutation; Neoplasm Proteins; Neoplasms; Nuclear Proteins; Oncogene Proteins; Oncogene Proteins, Fusion; Proto-Oncogene Proteins c-myc; Transcription Factors; Triazoles; Vorinostat; Young Adult | 2012 |
Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 1; Dipeptidyl-Peptidase IV Inhibitors; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Female; Histone Deacetylase Inhibitors; Hydroxamic Acids; Insulin-Secreting Cells; Mice; Mice, Inbred NOD; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1; Triazoles; Vorinostat | 2013 |
Preventing graft-versus-host disease: transplanters glimpse hope beyond immunosuppressants.
Topics: Acute Disease; Bone Marrow Transplantation; Boronic Acids; Bortezomib; Chronic Disease; Clinical Trials as Topic; Cyclohexanes; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hydroxamic Acids; Immunosuppressive Agents; Maraviroc; Methotrexate; Pentostatin; Peripheral Blood Stem Cell Transplantation; Pyrazines; Quality of Life; Tacrolimus; Triazoles; Vorinostat | 2013 |
New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.
Topics: Anti-HIV Agents; Azepines; Bryostatins; CD4-Positive T-Lymphocytes; Cell Cycle Proteins; Depsipeptides; Disulfiram; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Hydroxamic Acids; Indoles; Ionomycin; Lymphocyte Activation; Nuclear Proteins; Panobinostat; Tetradecanoylphorbol Acetate; Transcription Factors; Triazoles; Virus Latency; Vorinostat | 2014 |
Discovery of PAT-1102, a novel, potent and orally active histone deacetylase inhibitor with antitumor activity in cancer mouse models.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; HCT116 Cells; HeLa Cells; Histone Deacetylase Inhibitors; Human Umbilical Vein Endothelial Cells; Humans; Hydroxamic Acids; Inhibitory Concentration 50; Male; Mice, Inbred BALB C; Mice, Nude; Mice, SCID; Neoplasms, Experimental; Neovascularization, Pathologic; Triazoles; Vorinostat; Xenograft Model Antitumor Assays | 2015 |
Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells.
Topics: Acetamides; Astrocytes; Azepines; Cell Line; Cell Survival; Depsipeptides; Disulfiram; Fetus; Histone Deacetylase Inhibitors; HIV-1; Humans; Hydroxamic Acids; Indoles; Macrophages; Neurons; Panobinostat; Piperazines; Primary Cell Culture; Transcription, Genetic; Triazoles; Virus Activation; Virus Latency; Virus Replication; Vorinostat | 2016 |
YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis.
Topics: Adaptor Proteins, Signal Transducing; Angiomotins; Animals; Antineoplastic Agents; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; HEK293 Cells; Hippo Signaling Pathway; Humans; Intercellular Signaling Peptides and Proteins; Mice; Mice, Transgenic; Microfilament Proteins; Muscle, Skeletal; NF-kappa B; Phosphoproteins; Protein Serine-Threonine Kinases; RNA Interference; RNA, Small Interfering; Sarcoma; Signal Transduction; Soft Tissue Neoplasms; Transcription Factors; Triazoles; Ubiquitin-Specific Proteases; Vorinostat; YAP-Signaling Proteins | 2018 |
Novel Hydroxamic Acids Incorporating 1-((1H-1,2,3-Triazol-4-yl)methyl)- 3-substituted-2-oxoindolines: Synthesis, Biological Evaluation and SAR Analysis.
Topics: Antineoplastic Agents; Catalytic Domain; Cell Line, Tumor; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Molecular Docking Simulation; Structure-Activity Relationship; Triazoles; Vorinostat | 2018 |
YAP1 enhances NF-κB-dependent and independent effects on clock-mediated unfolded protein responses and autophagy in sarcoma.
Topics: Activating Transcription Factor 6; Adaptor Proteins, Signal Transducing; Animals; Autophagy; Azepines; Cell Cycle Proteins; Cell Differentiation; Cell Line; Cell Transformation, Neoplastic; Circadian Clocks; CLOCK Proteins; eIF-2 Kinase; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Transgenic; Muscle Neoplasms; Muscle, Skeletal; Myoblasts; NF-kappa B; Sarcoma; Signal Transduction; Stem Cells; Triazoles; Unfolded Protein Response; Vorinostat; YAP-Signaling Proteins | 2018 |
Synergistic effects of vorinostat (SAHA) and azoles against Aspergillus species and their biofilms.
Topics: Aspergillus; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; Azoles; Biofilms; Drug Synergism; Gene Expression Regulation; HSP90 Heat-Shock Proteins; Itraconazole; Microbial Sensitivity Tests; Plankton; Triazoles; Voriconazole; Vorinostat | 2020 |